![Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/bf27a8f33dc1177ab0c7cf3c2adec21f5727b20d/3-Table1-1.png)
Table 1 from Clinical performance of LOCI™-based tumor marker assays for tumor markers CA 15-3, CA 125, CEA, CA 19-9 and AFP in gynecological cancers | Semantic Scholar
![Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer](https://www.spandidos-publications.com/article_images/ol/20/1/ol-20-01-0742-g01.jpg)
Clinical significance and diagnostic value of serum NSE, CEA, CA19‑9, CA125 and CA242 levels in colorectal cancer
![Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma - Gynecologic Oncology Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma - Gynecologic Oncology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/639bcddb-7341-409a-b8f6-54f99538a3ef/gr1.jpg)
Combining CA 125 and SMR serum markers for diagnosis and early detection of ovarian carcinoma - Gynecologic Oncology
![Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net](https://labpedia.net/wp-content/uploads/2020/01/Tumor-marker-diagnosis-prognosis-3-1024x807.jpg)
Tumor Marker:- Part 4 - CA-Antigens, CA 15-3, CA 549, CA 27.29, CA 125, CA 19-9, CA 72-4 - Labpedia.net
![Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer | Insight Medical Publishing Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer | Insight Medical Publishing](https://www.aclr.com.es/articles-images/annals-clinical-four-tumor-marker-3-3-32-g001.png)
Evaluation of Four Tumor Markers (CEA, AFP, CA125 and CA19-9) on Sysmex HISCL- 5000 Immunoassay Analyzer | Insight Medical Publishing
![PDF) Review of Carcinoma Antigen 125 (CA 125) as a marker of disease progression or recurrence in clinical trials. PDF) Review of Carcinoma Antigen 125 (CA 125) as a marker of disease progression or recurrence in clinical trials.](https://www.researchgate.net/profile/Amit-Garg-16/publication/242489940/figure/fig1/AS:436456624791552@1481070776069/CA-125-response-in-relapsed-trials_Q320.jpg)